BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 29, 2010
View Archived Issues
How Melanoma Gets Around PLX4032: Counting The Ways
Read More
NewCo News: MabVax Pursues Two-Pronged Approach to Immunotherapies
Read More
Stock Movers
Read More
Holiday Notice
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Bench Press
Read More
Below-Range Pricing Remains, Anacor's IPO Brings in $60M
Investors continued their unenthusiastic reaction to biotech IPOs with last week's initial public offering from Anacor Pharmaceuticals Inc. (BioWorld Today)
Read More
Alnylam CEO: Big Pharma Still Confident in Potential of RNAi
Read More